Amanda E.

We've noticed a surge in small and midsized pharma companies creating (or improving) medical affairs websites and here's why: -Data Sharing: Companies reach a point where they have enough data to justify a dedicated site -Trust Building: These sites enhance credibility and transparency (we all know how important and challenging HCP trust is) -Compliance: Easier to meet regulatory requirements -Engagement: Improved access to info for HCPs, regulators and even patients We've written an article on best practices for med affairs sites. Check it out here: https://lnkd.in/eWi6fEry emagineHealth is the Digital-First Marketing Agency for Biopharma.  Let's chat! dgadless@emagine.com

8

1 Comment

We've noticed a surge in small and midsized pharma companies creating (or improving) medical affairs websites and here's why: -Data Sharing: Companies reach a point where they have enough data to justify a dedicated site -Trust Building: These sites enhance credibility and transparency (we all know how important and challenging HCP trust is) -Compliance: Easier to meet regulatory requirements -Engagement: Improved access to info for HCPs, regulators and even patients We've written an article on best practices for med affairs sites. Check it out here: https://lnkd.in/eWi6fEry emagineHealth is the Digital-First Marketing Agency for pharma and healthcare.

1

Build rather than buy an RBQM solution? Really? There must be something in the air at #OCTEastCoast because we've just had another "interesting" conversation, this time with a mid-sized Sponsor. They are building their own #RBQM solution. Really? Why? Would you build a new CTMS or EDC? Would you go to the time, expense, hassle, and risk of developing a new system when you can buy a proven, validated, secure, and scalable solution that's ready to go? A solution you don't have to maintain, managed by experts and that is constantly evolving with the latest from the sector. Even big Sponsors are coming to us and saying their attempts to develop in-house RBQM solutions haven't delivered the results they want or need, and are too expensive to maintain. Build rather than buy an RBQM solution? Really? The numbers just don't add up.

12

As we head into brand planning season, it's time to revisit your Part D strategy. A few questions to consider: 🔹 Is your PAP program strategically positioned w/ appropriate eligibility criteria given the IRA 2025 Part D redesign? Do you know how your competition is adjusting their program(s)? 🔹Are your HCPs and patients aware that enrollment is required for the Medicare Prescription Payment Plan (MPPP) program in order to "smooth" out-of-pocket costs? How will you provide education on the Part D redesign? 🔹 Part D plans are considering narrowing benefits to account for significantly higher financial liability - How are you engaging payers digitally and sharing current value messaging? 🔹 Are your field teams prepared to discuss these changes with customers? If you've attended an industry conference lately then you know Corey Ford is THE IRA guy. Bring the A team to the table. Reach out today to get started.

23

1 Comment

Thoughts on this? >> Buckle in: Gene therapy AMT-130 appears to slow down signs of Huntington’s disease in Phase I/II clinical trial - HDBuzz >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #pharma #pharmaceutical #biotech #competitivemarketing

1

Thoughts on this? >> Regeneron and Genentech battle for ophthalmologists’ affinity in Eylea HD, Vabysmo matchup >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #pharmaceutical #healthcare #productmarketing #biotech

2

May is recognized as Melanoma Awareness Month, a crucial time to highlight the importance of regular dermatology cancer screenings. I wanted to share my personal experience with melanoma to emphasize the significance of early detection. Around nine months ago, I received a melanoma diagnosis. Fortunately, it was caught in its early stages, allowing for complete removal through a single surgery. It was sheer luck that I noticed a discoloration in the back of my arm while looking in the bathroom mirror. Promptly getting it examined was critical in preventing the cancer from progressing further. Sadly enough, it took this scare for me to start taking the risks of melanoma seriously. Melanoma diagnoses are alarmingly common, with approximately 900 people being diagnosed each day. Tragically, not everyone is as fortunate as me, as one person loses their life to melanoma every ten minutes. These statistics underscore the importance of taking preventive measures. Wearing sunscreen, limiting exposure to UV light, and paying attention to changes on your skin can genuinely be life-saving. It is crucial to proactively monitor any suspicious moles, growths, or changes in color or texture. Early detection significantly increases the chance of successful treatment and recovery. Let's spread awareness this Melanoma Awareness Month by encouraging our loved ones to prioritize dermatology cancer screenings and adopt sun-safe practices. Together, we can make a difference in reducing the impact of melanoma and saving lives. Stay safe and protect your skin!

46

5 Comments

This content is intended for U.S. audiences only. The countdown to Chicago is on, as we gear up for #ASCO24 in less than two weeks! For the first time, @AstraZeneca will headline not one, but TWO back-to-back plenary sessions in LUNG as well as a late-breaking study in BREAST. Our team is focused on treating cancers at earlier stages and across subtypes while advancing medicines and combination therapies that attack the disease from all angles, evidenced by our strong, diverse research to be presented in Chicago. Behind every data point is a patient, who deserves a personalised therapy that will give them a longer and healthier life. For each one, we’re pushing the boundaries of science, and I can’t wait to highlight our research advances in the coming weeks. Stay tuned! 🔬 For a more detailed preview of our #ASCO24 data presentations, please see our press release https://lnkd.in/ehH7tqFc #CancerResearch #oncology #MedicalAdvancements

224

3 Comments

Ten years ago this guy in the hoodie was asking how to get more involved with industry. Now he’s teaching others how to do it! It wasn’t that long ago that Blake Williamson, MD, MPH, MS approached Leo Edward Otero and me, curious how to work with industry. It’s awesome that the recent YoungMD Connect has given Blake a platform to share these learnings with others. Congratulations Tamara Bogetti, MBA and the BMC team for creating this incredible forum for leaders like Blake, Ashley Brissette, Tarsus marketing VP Matt Rossen, and others to pay it forward! Here are some tips for physicians who want to collaborate with industry. Please share more! - Find products and disease states that you’re really passionate about - Develop a strong relationship with your SMA / MSL / sales rep to learn about opportunities on both the medical and marketing sides of the company. Customer facing leaders in industry will be your biggest advocates. - Choose companies whose values and culture you align with. You become an extension of that organization when you get involved with them - are they a good fit for your brand and are you a good fit for their brand? - Determine where you can make the biggest impact - are you a great presenter, researcher, writer, social media content creator, innovator, advisor? Be open about your talents and explore where you can make a fulfilling difference at the companies you collaborate with. - Read about the PhRMA and Advamed codes to understand what compliance guidelines will be in place and know that each company may each have additional guidelines to follow. - Review industry contracts carefully to ensure you’re comfortable with any restrictions - understand what scope of work is covered and be sure you’re not limiting other opportunities. - Realize that industry activities may happen after hours or on weekends and be willing to commit the time. - Leverage Industry gatherings like investigator meetings and advisory boards for networking with other physicians involved in industry to learn and share best practices. 💡Come to conferences like YMDC and learn from experts like Blake! 📸 photo cred: Pamela Marans Katz WILLIAMSON EYE CENTER Bryn Mawr Communications Tarsus Pharmaceuticals, Inc. #Pharmaceuticals #medicalaffairs #industry #physician #collaboration #ophthalmology #eyecare #YMDC

166

6 Comments

In this PM360 article, our expert Cameron Thompson outlines two major shifts in engaging physicians. Dive in: https://ow.ly/tJ4z30sBXyu #SyneosHealth

3

At TriNetX, we are motivated by the potential for improving patients' lives. Our healthcare organizations have made huge strides in research and securing more sponsored trials, in order to achieve better patient outcomes. Learn more about what drives us: https://ow.ly/goif30sERxm #HealthcareInnovation #RealWorldData

8

Here's how I help my clients with Clarity: 1. Communications Clarity workshops to help teams become great at getting to the point (and getting the point across). 2. Short-term brand consulting (individuals/SMB) to arrive at a clear, concise, and compelling messaging. 3. Keynotes on immediately actionable practices that energize any group yearning for success. How can I help you? Link in the comments.

18

2 Comments

There are dozens of new #GLP1s currently in development. Many plan sponsors in the market are struggling with how best to approach this exploding drug category. Let’s chat about the trends my team and I are watching–and how MedImpact Healthcare Systems, Inc. helps #payers support members who can benefit from these therapies. #wearemedimpact #atruepartner #healthcare #drugtrends

6